Inovio Pharmaceuticals
INO
INO
212 hedge funds and large institutions have $723M invested in Inovio Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 88 increasing their positions, 48 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
4% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 50
53% less capital invested
Capital invested by funds: $1.52B → $723M (-$801M)
Holders
212
Holding in Top 10
–
Calls
$117M
Puts
$104M
Top Buyers
| 1 | +$16.5M | |
| 2 | +$14.7M | |
| 3 | +$10.8M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$10.3M |
| 5 |
Coatue Management
New York
|
+$9.59M |
Top Sellers
| 1 | -$20.8M | |
| 2 | -$16M | |
| 3 | -$13.9M | |
| 4 |
Jane Street
New York
|
-$5.7M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$5.45M |